Taste and smell perception and quality of life during and after systemic therapy for breast cancer
- PMID: 29476290
- PMCID: PMC5993854
- DOI: 10.1007/s10549-018-4720-3
Taste and smell perception and quality of life during and after systemic therapy for breast cancer
Abstract
Purpose: The purpose of the study was to assess self-reported taste and smell perception after chemotherapy in breast cancer patients compared with women without cancer, and to assess whether taste and smell perception is associated with quality of life after the end of chemotherapy.
Methods: We included 135 newly diagnosed breast cancer patients who completed chemotherapy and 114 women without cancer. Questionnaires on taste, smell, and quality of life were completed shortly after and 6 months after chemotherapy (patients) or at two moments with 6 months' time window in between (comparisons).
Results: Self-reported taste and smell perception were significantly lower in patients shortly after chemotherapy compared to the comparison group. Most patients recovered 6 months after chemotherapy, although patients who were still receiving trastuzumab then reported a lower taste and smell perception compared to patients who were not. A lower self-reported taste and smell were statistically significantly associated with a worse quality of life, social, emotional, and role functioning shortly after chemotherapy. Six months after chemotherapy, taste and smell were statistically significantly associated with quality of life, social and role functioning, but only in patients receiving trastuzumab.
Conclusions: Most taste and smell alterations recovered within 6 months after the end of chemotherapy for breast cancer, but not for patients receiving trastuzumab. These results highlight the importance of monitoring taste and smell alterations during and after treatment with chemotherapy and trastuzumab, as they may impact quality of life.
Keywords: Breast cancer; Chemotherapy; Dysgeusia; Herceptin; Quality of life; Smell; Taste; Taste loss; Trastuzumab.
Conflict of interest statement
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical approval
All procedures performed in the study described in this manuscript were in accordance with the ethical standards of the institutional and/or national research committee.
Figures



Similar articles
-
Chemotherapy-induced taste and smell changes influence food perception in cancer patients.Support Care Cancer. 2021 Apr;29(4):2125-2132. doi: 10.1007/s00520-020-05717-1. Epub 2020 Sep 1. Support Care Cancer. 2021. PMID: 32870414
-
Assessing taste and smell alterations in cancer patients undergoing chemotherapy according to treatment.Support Care Cancer. 2018 Dec;26(12):4077-4086. doi: 10.1007/s00520-018-4277-z. Epub 2018 May 31. Support Care Cancer. 2018. PMID: 29855774
-
The impact of taste and smell alterations on quality of life in head and neck cancer patients.Qual Life Res. 2016 Jun;25(6):1495-504. doi: 10.1007/s11136-015-1185-2. Epub 2015 Nov 20. Qual Life Res. 2016. PMID: 26589527
-
Disturbances of taste and smell induced by drugs.Pharmacotherapy. 1997 May-Jun;17(3):482-96. Pharmacotherapy. 1997. PMID: 9165552 Review.
-
Taste and smell disturbances in cancer patients: a scoping review of available treatments.Support Care Cancer. 2021 Jan;29(1):49-66. doi: 10.1007/s00520-020-05609-4. Epub 2020 Jul 30. Support Care Cancer. 2021. PMID: 32734392
Cited by
-
Association of oral toxicity and taste changes during hematopoietic stem cell transplantation: a preliminary study.Support Care Cancer. 2020 Mar;28(3):1277-1287. doi: 10.1007/s00520-019-04922-x. Epub 2019 Jun 24. Support Care Cancer. 2020. PMID: 31236700
-
Impact of taste/smell disturbances on dietary intakes and cachexia-related quality of life in patients with advanced cancer.Support Care Cancer. 2023 Jan 30;31(2):141. doi: 10.1007/s00520-023-07598-6. Support Care Cancer. 2023. PMID: 36715776
-
Protocol for the ASTRO study (SSOP-01): a multicentre prospective cohort study investigating adverse events based on electronic patient-reported outcomes in patients with breast cancer after adjuvant chemotherapy.BMJ Open. 2023 Sep 14;13(9):e071500. doi: 10.1136/bmjopen-2022-071500. BMJ Open. 2023. PMID: 37709306 Free PMC article.
-
Heterogeneity of vulnerability and taste changes in older cancer patients undergoing chemotherapy: a latent class analysis.Support Care Cancer. 2023 Jun 13;31(7):392. doi: 10.1007/s00520-023-07862-9. Support Care Cancer. 2023. PMID: 37310497
-
Nutrition Practices among Adult Cancer Survivors Living on the Island of Ireland: A Cross-Sectional Study.Nutrients. 2022 Feb 11;14(4):767. doi: 10.3390/nu14040767. Nutrients. 2022. PMID: 35215416 Free PMC article.
References
-
- de Vries YC, Helmich E, Karsten MDA, Boesveldt S, Winkels RM, van Laarhoven HWM. The impact of chemosensory and food-related changes in patients with advanced oesophagogastric cancer treated with capecitabine and oxaliplatin: a qualitative study. Support Care Cancer. 2016;24(7):3119–3126. - PMC - PubMed
-
- Gamper EM, Giesinger JM, Oberguggenberger A, Kemmler G, Wintner LM, Gattringer K, Sperner-Unterweger B, Holzner B, Zabernigg A. Taste alterations in breast and gynaecological cancer patients receiving chemotherapy: prevalence, course of severity, and quality of life correlates. Acta Oncol. 2012;51(4):490–496. doi: 10.3109/0284186X.2011.633554. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical